Valeria Mastrullo

Valeria Mastrullo

Auto-generated profile, based on publicly available information

Valeria Mastrullo

Section of Cardiovascular Sciences, Faculty of Health & Medical Sciences, University of Surrey, Guildford, GU2 7XH, United Kingdom

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
VMValeria Mastrullo
Valeria Mastrullo
WCWilliam Cathery
William Cathery
EVEirini Velliou
Eirini Velliou
PMPaolo Madeddu
Paolo Madeddu
PCPaola Campagnolo
Paola Campagnolo
Despite the steady increase in the number of studies focusing on the development of tissue engineered constructs, solutions delivered to the clinic are still limited. Specifically, the lack of mature and functional vasculature greatly limits the size and complexity of vascular scaffold models. If tissue engineering aims to replace large portions of tissue with the intention of repairing significant defects, a more thorough understanding of the mechanisms and players regulating the angiogenic process is required in the field. This review will present the current material and technological advancements addressing the imperfect formation of mature blood vessels within tissue engineered structures.

8 June 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
DLDaniella Andrea Lefteri
Daniella Andrea Lefteri
SBSteven R. Bryden
Steven R. Bryden
MPMarieke Pingen
Marieke Pingen
STSandra Terry
Sandra Terry
AMAilish McCafferty
Ailish McCafferty
CMClive McKimmie
Clive McKimmie
Viruses transmitted by Aedes mosquitoes are an increasingly important global cause of disease. Defining common determinants of host susceptibility to this large group of heterogenous pathogens is key for informing the rational design of panviral medicines. Infection of the vertebrate host with these viruses is enhanced by mosquito saliva, a complex mixture of salivary-gland-derived factors and microbiota. We show that the enhancement of infection by saliva was dependent on vascular function and was independent of most antisaliva immune responses, including salivary microbiota. Instead, the Aedes gene product sialokinin mediated the enhancement of virus infection through a rapid reduction in endothelial barrier integrity. Sialokinin is unique within the insect world as having a vertebrate-like tachykinin sequence and is absent from Anopheles mosquitoes , which are incompetent for most arthropod-borne viruses, whose saliva was not proviral and did not induce similar vascular permeability. Therapeutic strategies targeting sialokinin have the potential to limit disease severity following infection with Aedes -mosquito-borne viruses.

17 October 2016 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
MPMarco Piola
Marco Piola
MRMatthijs Ruiter
Matthijs Ruiter
RVRiccardo Vismara
Riccardo Vismara
VMValeria Mastrullo
Valeria Mastrullo
MAMarco Agrifoglio
Marco Agrifoglio
GFGianfranco Beniamino Fiore
Gianfranco Beniamino Fiore

19 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DLDaniella Andrea Lefteri
Daniella Andrea Lefteri
SBSteven R Bryden
Steven R Bryden
MPMarieke Pingen
Marieke Pingen
STSandra Terry
Sandra Terry
EBEmily Beswick
Emily Beswick
CMClive McKimmie
Clive McKimmie
Summary: Viruses transmitted by Aedes mosquitoes constitute an increasingly important global health burden. Defining common determinants of host susceptibility to this large group of heterogenous pathogens are key for informing the rational design of new pan-viral medicines. Infection of the vertebrate host with these viruses is enhanced by the presence of mosquito saliva, a complex mixture of salivary gland-derived factors and microbiota. We show that enhancement of infection by saliva was dependent on vascular function and was independent of most anti-saliva immune responses, including to salivary microbiota. Instead, the Aedes gene product sialokinin mediated enhancement of virus infection through a rapid reduction in endothelial barrier integrity. Sialokinin is unique within the insect world as having vertebrate-like tachykinin sequence and is absent from non-vector competent Anopheles mosquitoes, whose saliva was not pro-viral and did not induce similar vascular permeability. Therapeutic strategies targeting sialokinin have potential to limit disease severity following infection with Aedes mosquito-borne viruses.

14 June 2017 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
Cristina BanfiCristina Banfi
Cristina Banfi
AGAnna Guarino
Anna Guarino
MBMaura Brioschi
Maura Brioschi
SGStefania Ghilardi
Stefania Ghilardi
VMValeria Mastrullo
Valeria Mastrullo
GPGianluca Polvani
Gianluca Polvani
The protein composition of the human mitral valve is still partially unknown, because its analysis is complicated by low cellularity...

14 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
YCYin P. Cheung
Yin P. Cheung
VMValeria Mastrullo
Valeria Mastrullo
DMDavide Maselli
Davide Maselli
TBTeemapron Butsabong
Teemapron Butsabong
PMPaolo Madeddu
Paolo Madeddu
PCPaola Campagnolo
Paola Campagnolo
Dengue is the most prevalent arthropod-borne viral disease affecting humans, with severe dengue typified by potentially fatal microvascular leakage and hypovolaemic shock. Blood vessels of the microvasculature are composed of a tubular structure of endothelial cells ensheathed by perivascular cells (pericytes). Pericytes support endothelial cell barrier formation and maintenance through paracrine and contact-mediated signalling, and are critical to microvascular integrity. Pericyte dysfunction has been linked to vascular leakage in noncommunicable pathologies such as diabetic retinopathy, but has never been linked to infection-related vascular leakage. Dengue vascular leakage has been shown to result in part from the direct action of the secreted dengue virus (DENV) non-structural protein NS1 on endothelial cells. Using primary human vascular cells, we show here that NS1 also causes pericyte dysfunction, and that NS1-induced endothelial hyperpermeability is more pronounced in the presence of pericytes. Notably, NS1 specifically disrupted the ability of pericytes to support endothelial cell function in a 3D microvascular assay, with no effect on pericyte viability or physiology. These effects are mediated at least in part through contact-independent paracrine signals involved in endothelial barrier maintenance by pericytes. We therefore identify a role for pericytes in amplifying NS1-induced microvascular hyperpermeability in severe dengue, and thus show that pericytes can play a critical role in the aetiology of an infectious vascular leakage syndrome. These findings open new avenues of research for the development of drugs and diagnostic assays for combating infection-induced vascular leakage, such as severe dengue. SIGNIFICANCE STATEMENT: The World Health Organisation considers dengue one of the top ten global public health problems. There is no specific antiviral therapy to treat dengue virus and no way of predicting which patients will develop potentially fatal severe dengue, typified by vascular leakage and circulatory shock. We show here that perivascular cells (pericytes) amplify the vascular leakage-inducing effects of the dengue viral protein NS1 through contact-independent signalling to endothelial cells. While pericytes are known to contribute to noncommunicable vascular leakage, this is the first time these cells have been implicated in the vascular effects of an infectious disease. Our findings could pave the way for new therapies and diagnostics to combat dengue, and potentially other infectious vascular leakage syndromes.